Activation Of Neurogenesis Improves Amyloid-Β Pathology And Cognitive Function Through AMP Kinase Signaling In Alzheimer’S Disease Model Mice
Our brains naturally generate new cells in a region vital for learning and memory, a process called adult hippocampal neurogenesis. However, this process slows down with age and is significantly impaired in conditions like Alzheimer’s disease, contributing to cognitive decline. Researchers have been exploring ways to boost this natural brain repair mechanism.
In a recent study, scientists investigated a method previously shown to rejuvenate aged neural stem cells—the foundational cells that produce new brain cells. When applied to mice modeling Alzheimer’s disease, this treatment successfully increased the production of new brain cells. Crucially, it also led to a reduction in amyloid-beta deposits, which are harmful protein clumps characteristic of Alzheimer’s, and improved the mice’s cognitive abilities, such as memory.
Further investigation pinpointed a specific gene, Prkag2, as a key player in these beneficial effects. Reducing the activity of this gene in the brain also enhanced the birth of new neurons and decreased amyloid-beta accumulation. Both the rejuvenating treatment and the gene targeting achieved these results by activating a critical cellular pathway known as AMP-activated protein kinase (AMPK) signaling. This activation, in turn, boosted genes involved in cellular “housekeeping” and maintaining overall cell health.
These findings suggest that focusing on the Prkag2 gene and the AMPK pathway could open new avenues for developing therapies to combat Alzheimer’s disease and other neurodegenerative conditions by promoting the brain’s own regenerative capabilities.
Source: link to paper